The United Kingdom has become the first country to give regulatory approval to a medical treatment involving the revolutionary CRISPR gene editing tool.

Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer's.

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.

CRISPR-based diagnostics offer transformative solutions for disease detection, utilizing advanced gene-editing tools for precise and rapid molecular testing.

The Center for Pediatric CRISPR Cures will start by creating custom therapies for eight patients with rare immune or metabolic genetic diseases.